This study is in progress, not accepting new patients
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- BMS Clinical Trial Information BMS Clinical Trial Patient Recruiting Investigator Inquiry Form FDA Safety Alerts and Recalls
- ID
- NCT02181738
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated